Potential side effects (rare but possible): Injection site reactions (redness, mild swelling) Water retention with growth hormone peptides Temporary insulin sensitivity changes Mild headaches or fatigue during initial weeks What actually matters for safety: Source quality : Pharmaceutical-grade peptides from FDA-registered compounding pharmacies only
Safety and efficacy of mevidalen in Lewy body dementia: a phase 2, randomized, placebocontrolled trial
in Nature (1980)
Abstract Introduction: To evaluate the efficacy of a novel eye drop formulation containing hyaluronic acid (0.2%) and butyroyl-glutathione (GSHC4, 0.4%) in glaucoma-associated ocular surface disease (G-OSD), and to explore putative mechanisms of action through in vitro assays of corneal epithelial wound healing and cytokine modulation under basal, inflammatory, and oxidative stress conditions
We examine their pro-oxidant and antioxidant capacities, involvement in redox signaling and metabolic pathways, stress responses, and their role in the pathophysiology of major disease groups, including cardiovascular and neurodegenerative diseases and cancer
To view a copy of this license, visit About this article Cite this article Draper, C.F., Duisters, K., Weger, B
